New Medication Available for IBS-C TRULANCE® (plecanatide tablets) for Irritable Bowel Syndrome with Constipation in Adults Is now Available to Canadians to Help Meet Treatment Gap that leaves 70 Per cent of Patients Unsatisfied1 LAVAL, QC, February 8, 2022 - Bausch Health, Canada, part of Bausch Health Companies Inc. (NYSE/TSX: BHC), ("Bausch Health" or the "Company") today announced the availability [...]
IBD Patient Journey Survey Are you living with an inflammatory bowel disease (IBD)? Take this survey to let us know your opinions and outlook on living with and managing this chronic disease. This survey is open to Canadians who have received a diagnosis for IBD (Crohn’s disease, ulcerative colitis, ulcerative proctitis, microscopic colitis, and indeterminate [...]
Survey Report: Biosimilars in Alberta and BC Four provinces across Canada have implemented non-medical switching (NMS) policies for biologic medications. In these jurisdictions, to maintain public coverage, individuals must switch from their originator biologic to a corresponding biosimilar. In May 2019, the government of British Columbia (BC) launched their NMS policy and Alberta followed shortly [...]
Bone Health Survey Results Bone is living tissue. Our bodies continually remove or resorb old bone and form new bone. Strong bone is a result of both the density and quality of bone. Healthy bone development involves the intake of nutrients, such as calcium, vitamin D, and phosphorus, along with mechanical force via weight-bearing exercise. [...]
Your Rights to Personal Health Data Along with twenty other patient organizations and individual advocates, the Gastrointestinal Society has endorsed the Declaration of Personal Health Data Rights in Canada.1 People own their personal health data while stewards of that data own the records. Since people own their personal health data, they have corresponding rights over [...]
Poop Anxiety Survey Are you afraid to poop in public washrooms? What about at a friend’s house? Whether pooping outside of your house makes you nervous, or you're comfortable going anywhere there’s a toilet, we want to hear from you. Take our survey to let us know. The Gastrointestinal Society represents Canadians on a variety [...]
Biosimilars Survey 2021 The Gastrointestinal Society represents Canadian patients on a variety of healthcare fronts, including access to medications. We have designed this survey to help us understand your opinions and outlook regarding switching from originator biologics to their biosimilars. We will use this information anonymously and in aggregate to shape future programming and to [...]
More PMPRB Revisions During Legal Challenges, COVID-19, and an Election As you may know, the Patented Medicine Prices Review Board (PMPRB), is a quasi-judicial federal agency that calculates the maximum prices of patented medicines. There have been several developments in the past few years, including three delays to the implementation of the PMPRB changes, court [...]
Short Bowel Syndrome Video We have just released a new video on short bowel syndrome. Short bowel syndrome occurs when an individual doesn’t have enough small intestine to properly absorb nutrients from food. It can occur after any surgery that involves the removal if 50% or more of the small intestine. This [...]
Changes to How Drugs Are Priced in Canada and Why This Should Matter to You Update: On June 29, 2021, Health Canada has, again, postponed the implementation date of the new PMPRB changes from July 1, 2021 to January 1, 2022 in recognition of the ongoing challenges brought by the COVID-19 [...]
